Nerve injury or dysfunction in the peripheral and central nervous systems are the ... prerequisite for the rational development of novel analgesic drugs for the therapy of neuropathic pain.
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) ...
Peripheral or central activation of the TRPM8 (transient receptor potential melastatine family member 8) cool-sensitive ion channel can produce an analgesic effect, reversing hypersensitivity and ...